Ehsan Rahimy, MD, says most PRIMA serious adverse events occurred early, while vision gains held through 36 months.

A new PLOS Pathogens study finds that the microRNA-1246 regulates macrophage lipid metabolism and helps explain why some ...

By merging bulk and single-cell RNA sequencing with machine learning and lab experiments, researchers have identified smooth ...

Kura Oncology (NASDAQ:KURA) and its newly formed affiliate Caspian Therapeutics outlined plans to develop KO-7246, an oral menin inhibitor, for diabetes, citing preclinical data that the companies ...

Executive Vice President and Chief Financial Officer - Joseph J. Wolk Executive Vice President, Worldwide Chairman, ...

Johnson & Johnson reported third-quarter 2026 adjusted earnings and revenue that edged past Wall Street expectations, but the ...